Premenstrual dysphoric disorder: Diagnosis and treatment;Trouble dysphorique premenstruel: Approche diagnostique et therapeutique

Revue du Praticien

Volumn 47, Issue 17, 1997, Pages 1907-1912

  Guedj, Françoise ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ATENOLOL; BROMOCRIPTINE; BUSPIRONE; CLOMIPRAMINE; CLONIDINE; DESIPRAMINE; DIURETIC AGENT; DOXYCYCLINE; ESTRADIOL; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GONADORELIN; LITHIUM; MAPROTILINE; NALTREXONE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PROGESTERONE; SERTRALINE; THYROXINE; SEX HORMONE;

DRUG EFFICACY; FEMALE; HUMAN; METHODOLOGY; PREMENSTRUAL SYNDROME; SHORT SURVEY; CENTRAL NERVOUS SYSTEM; DEPRESSION; IRRITABILITY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

CENTRAL NERVOUS SYSTEM; DEPRESSION; FEMALE; GONADAL STEROID HORMONES; HUMANS; IRRITABLE MOOD; MALE; PREMENSTRUAL SYNDROME;

EID: 0031262240     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Holsboer F. Neuroendocrinology of mood disorders. In: Psychopharmacology : the fourth generation of progress. Bloom F, Kupfer D (eds). New York : 1995.
2. Hazard J, Perlemuter L. L'homme hormonal. Hazan, 1995.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC American Psychiatric Association. 1994.
4. Chaturverdi S, Chandra P, Gururaj G et al. Suicidal ideas during premenstrual phase. J Affect Disord 1995; 43: 193-9.
5. Gold JH, Severino SK. Premenstrual dysphorias: Myths and realities. Washington DC London : American Psychiatric Press Inc. 1994.
6. Freeman E Rickeis K, Schweizer E et al. Relationship between age and symptom severity among women seeking medical treatment for premenstruel symptoms. Psychol Med 1995; 25: 309-15.
7. Yonkers K, White K. Premenstrual exacerbation of depression: one process or two? J Clin Psychiatry 1992; 53: 289-92.
8. Stephans WA. A cross cultural study of menstrual taboo. Genet Psychol Monogr 1961; 64: 385-416.
9. Fabrega H Jr. Cultural relativism and psychiatric illness. J Nerv Ment Dis 1989; 177: 415-30.
10. Van den Akker O, Eves F, Stein G et al. Genetic and environnemental factors in premenstrual symptom reporting and its relationship to depression and a general neuroticism trait J Psychosom Res 1995; 39: 477-87.
11. Severino SK. Menstrual cycle experience, In female psychology: An annotated psychoanalytic bibliography. Schuker E, Levinson NA, Hillside NJ (eds). Analytic Press, 1991: 183-93.
12. Hammerbäck S, Ekholm UB, Bäckström T. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol 1991; 125: 132-7.
13. Brzezinski A. Serotonin and premens-trual dysphoric disorder. Lancet 1996; 17: 470-1.
14. Kantero RL, Widhoim O. Statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers, IV: Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynecol Scand Suppl 1971 ; 14: 30-6.
15. Dalton K, Dalton M, Guthrie K. Incidence of the premenstrual syndrome in twins. BMJ 1987; 295: 1027-8.
16. Christensen AP, Oei TP. The efficacy of cognitive behaviour therapy in treating premenstrual dysphorlc changes. J Affect Disord 1995; 33: 57-63.
17. FiyzGerald M, Malone KM, Li S et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 1997; 154: 556-8.
18. Freeman EW. Rickeis K, Sondheimer SJ et al. A double-blind trial of oral progesterone, alprazolam, and placebo In treatment of severe premenstrual syndrome. JAMA 1995; 274: 51-7.
19. Edbril SD. Fluoxetine for premenstrual dysphoria. N Engl J Med 1995; 26: 1152-3.
20. Freeman EW, Rickels K, Sondheimer SJ et al. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. J Clin Psychiatry 1996; 57: 7-11
21. Yonkers KA, Halbreich U, Freeman E et al. Sertraline In the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 1996; 32: 41-6.
22. Yonkers KA, Gullion C, Williams A et al. Paroxetine as a treatment for premenstrual dysphoric disorder, J Clin Psychopharmacol 1996; 16: 3-8.
23. Eriksson E, Hedberg MA, Andersch B et al. The serotonin reuptake inhibitor paroxetin in superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995; 12: 167-76.
24. Freeman EW, Rickels K, Sondheimer SJ. Fluvoxamine for premenstrual dysphoric disorder: a pilot study. J Clin Psychiatry 1996; 57: 56-9.
25. Choi PY, Salmon P. Symptom changes across the menstrual cycle in competitive sportswomen, exercisers and sedentary women. Br J Clin Psychol 1995; 34: 447-60.
26. Koeske RK, Koeske GF. An attributional approach to mood and the menstrual cycle. J Pers Soc Psychol 1975; 31: 473-8.
27. Dalton K. The menstrual cycle. New York: Pantheon, 1969.